The good news, Dexcom CGM is accessible to more people with diabetes now than ever before, and can be an ideal complement to starting, changing, or adjusting GLP-1 medications
The cardiometabolic improvements seen during semaglutide treatment reverted towards the baseline in our study, similar to the findings in the STEP 1 study ( When interpreting the endocrine and cardiometabolic outcomes, it is important to highlight that participants in our cohort were already treated with metformin before the semaglutide intervention, therefore prior the baseline assessment
We recommend aiming for about 150 minutes of moderate intensity exercises or 75 minutes of vigorous exercise every week, says Dr
The average age of GLP-1 medication users in the UK is 44 years , with people aged 40-59 making up more than half of users (53.5%)
Paraptosis-a distinct pathway to cell death